Virility Medical Files Patent Infringement Lawsuit Against Morari Medical
HOD HASHARON,
The complaint asserts that Morari's MOR product infringes three
Morari recently announced that it received clearance from the United States Food and Drug Administration ("FDA") to market the MOR product. As explained in the recently filed complaint, Morari's FDA submission asserted that the MOR product is "substantially equivalent" to Virility Medical's own FDA cleared product. Indeed, Morari's CEO,
The Virility Medical patents asserted in the complaint are
About Virility Medical
Virility Medical is a consumer healthcare company specializing in sexual health and dedicated to enhancing sexual wellbeing. Virility Medical's patented technology, which is marketed under the brand name in2, provides a drug-free treatment for premature ejaculation, one of the most common male sexual health concerns. The in2 device was subjected to clinical testing, resulting in marketing clearance from United States Food and Drug Administration, CE marking obtained for distribution in
View original content to download multimedia:https://www.prnewswire.com/news-releases/virility-medical-files-patent-infringement-lawsuit-against-morari-medical-302419017.html
SOURCE Virility Medical Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Larry Ellison Cancels His Plan to Sell Oracle Stock
- Licensed Producer Dmitry Borovoy Launches SafeBridge, a Bilingual Trucking Insurance Desk for New Carriers
- International Association for the Study of Lung Cancer Launches Complimentary IASLC Full Membership for Eligible Countries to Expand Worldwide Participation in Thoracic Oncology
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share